TR201722950A2 - Koah tedavisinde yeni farmasötik bileşimler. - Google Patents
Koah tedavisinde yeni farmasötik bileşimler. Download PDFInfo
- Publication number
- TR201722950A2 TR201722950A2 TR2017/22950A TR201722950A TR201722950A2 TR 201722950 A2 TR201722950 A2 TR 201722950A2 TR 2017/22950 A TR2017/22950 A TR 2017/22950A TR 201722950 A TR201722950 A TR 201722950A TR 201722950 A2 TR201722950 A2 TR 201722950A2
- Authority
- TR
- Turkey
- Prior art keywords
- treatment
- pharmaceutical compositions
- copd
- new pharmaceutical
- new
- Prior art date
Links
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 abstract 1
- 229930195725 Mannitol Natural products 0.000 abstract 1
- 229960004308 acetylcysteine Drugs 0.000 abstract 1
- 235000010355 mannitol Nutrition 0.000 abstract 1
- 239000000594 mannitol Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Abstract
Mevcut buluş KOAH atakları tedavisinde kullanılacak N-Asetilsistein ve mannitol içeren farmasötik bileşimlere ilişkindir.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2017/22950A TR201722950A2 (tr) | 2017-12-29 | 2017-12-29 | Koah tedavisinde yeni farmasötik bileşimler. |
| PCT/TR2018/000134 WO2020022975A2 (en) | 2017-12-29 | 2018-12-28 | New pharmaceutical compositions in the treatment of copd |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2017/22950A TR201722950A2 (tr) | 2017-12-29 | 2017-12-29 | Koah tedavisinde yeni farmasötik bileşimler. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201722950A2 true TR201722950A2 (tr) | 2019-07-22 |
Family
ID=67901361
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2017/22950A TR201722950A2 (tr) | 2017-12-29 | 2017-12-29 | Koah tedavisinde yeni farmasötik bileşimler. |
Country Status (2)
| Country | Link |
|---|---|
| TR (1) | TR201722950A2 (tr) |
| WO (1) | WO2020022975A2 (tr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116098886B (zh) * | 2023-01-12 | 2024-04-26 | 澳门科技大学 | 一种药物组合物及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
| WO2006030221A1 (en) * | 2004-09-15 | 2006-03-23 | Cipla Limited | Pharmaceutical composition comprising a betaminetic agent and a mucolytic agent |
| CN102811715A (zh) * | 2009-12-08 | 2012-12-05 | 悉尼大学 | 可吸入制剂 |
-
2017
- 2017-12-29 TR TR2017/22950A patent/TR201722950A2/tr unknown
-
2018
- 2018-12-28 WO PCT/TR2018/000134 patent/WO2020022975A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020022975A3 (en) | 2020-02-27 |
| WO2020022975A2 (en) | 2020-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201791460A1 (ru) | N4-гидроксицитидин и связанные с ним производные и варианты противовирусного применения | |
| CL2016002027A1 (es) | Ciclopropilamina como inhibidor de la lsd1 | |
| EA201890204A1 (ru) | Антибактериальные соединения | |
| EA201790273A1 (ru) | Флагеллиновые композиции и их применение | |
| MX2018008052A (es) | Inhibidores de desmetilasa especifica de lisina 1 (lsd1). | |
| EA201990043A1 (ru) | Антибактериальные соединения | |
| EA201691726A1 (ru) | Новые 6-конденсированные гетероарилдигидропиримидины для лечения и профилактики заражения вирусом гепатита b | |
| CL2016001231A1 (es) | Compuestos de inhibidor de autotaxina | |
| CL2015000942A1 (es) | Compuestos de benceno sustituido. | |
| CL2016001609A1 (es) | Composiciones farmacéuticas que comprenden azd9291. | |
| EA201692529A1 (ru) | Способы и композиции для лечения расстройств с использованием фоллистатиновых полипептидов | |
| EA201991073A1 (ru) | Ингибиторы magl | |
| EA201791516A1 (ru) | Способы комбинированного лечения злокачественных опухолей | |
| EA201991074A1 (ru) | Ингибиторы magl | |
| CL2015002897A1 (es) | Inhibidores de bace1 | |
| EA201890810A1 (ru) | Соединения, эффективные для лечения гепатотоксичности и стеатоза печени, и их применение | |
| EA201790380A1 (ru) | Ингибиторы mk2 и их применения | |
| PH12018501279A1 (en) | Compositions comprising 15-hepe and methods of using the same | |
| EA201790787A1 (ru) | Снижение вязкости фармацевтических составов | |
| EA201692358A1 (ru) | Производные изоиндолина для применения в лечении вирусной инфекции | |
| EA201791174A1 (ru) | Антимикотическое соединение | |
| BR112017009000A2 (pt) | apilimod para uso no tratamento de melanoma | |
| EA201890364A1 (ru) | СОЕДИНЕНИЯ, ПРИГОДНЫЕ ДЛЯ ИНГИБИРОВАНИЯ ROR-ГАММА-t | |
| TR201820050T4 (tr) | Bromodomain inhibitörleri olarak tetrahidrokinolin türevleri. | |
| EA201791937A1 (ru) | Противовоспалительные полипептиды |